The Ombudsman’s Office and the Medical College of Peru (CMP) on Sunday (April 24) urged the country’s health authorities to immediately clarify the recent complaints about the application of a dose allegedly higher than the allowed one of Moderna’s fourth COVID-19 vaccine.
Through a statement, the Ombudsman’s Office announced the beginning of an investigation into the controversy unleashed last weekend, after several specialists and the CMP warned that the Ministry of Health (Minsa) was allegedly administrating 100 micrograms of Moderna’s COVID booster shot.
The debate started after doctors and nurses reported adverse side effects after allegedly receiving a dose higher than the recommended 50 micrograms for Moderna’s fourth vaccine, which began to be administrated in Peru this April to people over 70, immunosuppressed patients and health personnel.
The spokespersons of the Ministry of Health assured that from now on only 50 micrograms will be applied instead of the 100 micrograms that 96 000 people received from health personnel.